Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Robles

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Diabetology & Metabolic Syndrome|December 3, 2019
Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosusBetsabe Contreras-Haro, Sandra Ofelia Hernandez-Gonzalez, Laura Gonzalez-Lopez, et al.
Lancet Regional Health. Americas|December 1, 2025
Corrigendum to "Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"- the Lancet Regional Health-Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172Andrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativ, et al.
Lancet Regional Health. Americas|July 21, 2025
Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data studyAndrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativa, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Diabetology & Metabolic Syndrome|December 3, 2019
Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosusBetsabe Contreras-Haro, Sandra Ofelia Hernandez-Gonzalez, Laura Gonzalez-Lopez, et al.
Lancet Regional Health. Americas|December 1, 2025
Corrigendum to "Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"- the Lancet Regional Health-Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172Andrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativ, et al.
Lancet Regional Health. Americas|July 21, 2025
Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data studyAndrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativa, et al.
Pageof 8